Werewolf Therapeutics receives Nasdaq deficiency notice for low bid price; has until Nov 10, 2025 to cure

Werewolf Therapeutics, Inc.

Stock bid price closed below $1.00 for 30 consecutive business days, triggering Nasdaq deficiency notice.
Company has 180 calendar days until November 10, 2025 to regain compliance by closing at $1.00 for 10 consecutive business days.
If not cured, company may seek transfer to Nasdaq Capital Market for additional 180-day period, subject to other listing standards.
Failure to cure could lead to delisting; company plans to monitor bid price and evaluate available options.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.